Collaboration explores alpha-synuclein in disease-modifying therapies
A collaborative effort between the University of Oxford and Selvita will foster the development of potential disease-modifying therapies targeting…
Articles by Andrea Lobo
Real-time brain activity to guide study of personalized light therapy
Neuronic has partnered with Santa Clara University in Silicon Valley to develop a research project to study light…
New partners join forces to market Apple watch-based Parky app
h2o Therapeutics has partnered with AmerisourceBergen to commercialize Parky, a prescription mobile app that monitors symptoms in people…
Sinopia Biosciences selects SB-0110 for Phase 1 Parkinson’s trial
Sinopia Biosciences has selected SB-0110 as its lead clinical candidate for Parkinson’s disease after extensive preclinical studies. The move…
First healthy volunteer dosed in study of HER-096 for Parkinson’s
The first healthy volunteer has been dosed in a clinical study that will test the safety and efficacy of…
RAD-PD, registry into DBS use with Parkinson’s, finishes pilot phase
NeuroPoint Alliance’s (NPA) registry for people with Parkinson’s disease eligible for deep brain stimulation (DBS) surgery announced that…
Coffee drinking may diminish volume of striatum, key brain region
Heavier coffee drinkers, based on the number of cups consumed daily, have a lower volume of the striatum, a brain…
Women with Parkinson’s less likely to be referred for DBS than men
Women with Parkinson’s disease are less likely to be referred for deep brain stimulation (DBS) evaluation than men, a…
Faster gains seen with home apomorphine infusion in Parkinson’s
Home initiation of under-the-skin (subcutaneous) apomorphine infusion — a treatment for motor fluctuations — is faster at improving the life…
Exercise interventions found to ease motor symptoms in Parkinson’s
Physical exercise interventions can lessen Parkinson’s disease motor symptoms — and these beneficial effects are similar for both aerobic…